Ticker Details
Spruce Biosciences, Inc.
IPO Date:	October 9, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$148.24M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.92 | 5.96%
Avg Daily Range (30 D):	$0.98 | 2.06%
Avg Daily Range (90 D):	$1.61 | 2.97%

Institutional Daily Volume
Avg Daily Volume:	.5M
Avg Daily Volume (30 D):	.04M
Avg Daily Volume (90 D):	.05M

Trade Size
Avg Trade Size (Sh.):	218
Avg Trade Size (Sh.) (30 D):	34
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	81
Avg Institutional Trade:	$2.07M
Avg Institutional Trade (30 D):	$.57M
Avg Institutional Trade (90 D):	$2.84M
Avg Institutional Trade Volume:	.02M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.08M
Avg Closing Trade (30 D):	$.57M
Avg Closing Trade (90 D):	$4.36M
Avg Closing Volume:	41.64K

News

Apr 21, 2026 @ 9:15 AM Stock Market Today: Dow Jones, S&P 500 Futures Edg... Source: Benzinga Staff Writer

Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight

May 13, 2024 @ 9:10 PM Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, T... Source: Zacks Equity Research

May 1, 2024 @ 11:55 AM Pfizer (PFE) Q1 Earnings and Revenues Beat Estimat... Source: Zacks Equity Research

Mar 27, 2024 @ 4:00 PM Spruce Biosciences (SPRB) Upgraded to Buy: Here's ... Source: Zacks Equity Research

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-39.12	$-6.68	$-8.94
Diluted EPS	$-39.12	$-6.68	$-8.94
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-51.35M	$-16.23M	$-12.27M
Operating Income / Loss	$-47.83M	$-16.51M	$-11.99M
Cost of Revenue
Net Cash Flow	$109.14M	$86.54M	$22.61M
PE Ratio

Splits
Aug 07, 2025	1:75